Literature DB >> 11295592

Similarities of prostate and breast cancer: Evolution, diet, and estrogens.

D S Coffey1.   

Abstract

Environment determines the risk of both prostate and breast cancer, and this risk can vary >10-fold. In contrast, no risk exists for human seminal vesicle cancer demonstrating tissue specificity. There is also species specificity, because there is no risk for prostate cancer in any other aging mammal except the dog. A study of evolution indicates that the prostate and breast appeared at the same time 65 million years ago with the development of mammals. All male mammals have a prostate; however, the seminal vesicles are variable and are determined by the diet so that species primarily eating meat do not have seminal vesicles. The exception is the human, who has seminal vesicles and consumes meat, although this is a recent dietary change. Human lineage departed from other higher primates 8 million years ago. The closest existing primate to humans is the bonobo (pigmy chimpanzee), which does not eat meat but exists primarily on a high fruit and fresh vegetable diet. Homo sapiens evolved only about 150,000 years ago, and only in the last 10% of that time (10 to 15 thousand years ago) did humans and dogs dramatically alter their diets. This is the time when humans domesticated the dog, bred animals, grew crops, and cooked, processed, and stored meats and vegetables. All current epidemiologic evidence and suggestions for preventing prostate and breast cancer in humans indicates that we should return to the original diets under which our ancestors evolved. The recent development of the Western-type diet is associated with breast and prostate cancer throughout the world. It is believed that the exposure to and metabolism of estrogens, and the dietary intake of phytoestrogens, combined with fat intake, obesity, and burned food processing may all be related to hormonal carcinogenesis and oxidative DNA damage. An explanatory model is proposed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295592     DOI: 10.1016/s0090-4295(00)00938-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  31 in total

1.  Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.

Authors:  Xuan Chen; Yue Liu; Jian Wu; Huarong Huang; Zhiyun Du; Kun Zhang; Daiying Zhou; Kaylyn Hung; Susan Goodin; Xi Zheng
Journal:  Cancer Genomics Proteomics       Date:  2016 Mar-Apr       Impact factor: 4.069

2.  Exposure to ethinylestradiol during prenatal development and postnatal supplementation with testosterone causes morphophysiological alterations in the prostate of male and female adult gerbils.

Authors:  Ana Paula Silva Perez; Manoel Francisco Biancardi; Rejane Maira Góes; Fernanda Alcântara dos Santos; Sebastião Roberto Taboga
Journal:  Int J Exp Pathol       Date:  2011-02-12       Impact factor: 1.925

3.  A human fetal prostate xenograft model of developmental estrogenization.

Authors:  Camelia M Saffarini; Elizabeth V McDonnell-Clark; Ali Amin; Kim Boekelheide
Journal:  Int J Toxicol       Date:  2015-01-29       Impact factor: 2.032

Review 4.  The diet as a cause of human prostate cancer.

Authors:  William G Nelson; Angelo M Demarzo; Srinivasan Yegnasubramanian
Journal:  Cancer Treat Res       Date:  2014

5.  Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.

Authors:  Erin M McAuley; Devkumar Mustafi; Brian W Simons; Rebecca Valek; Marta Zamora; Erica Markiewicz; Sophia Lamperis; Anthony Williams; Brian B Roman; Chad Vezina; Greg Karczmar; Aytekin Oto; Donald J Vander Griend
Journal:  Am J Pathol       Date:  2017-08-18       Impact factor: 4.307

6.  Hedgehog-mesenchyme gene signature identifies bi-modal prognosis in luminal and basal breast cancer sub-types.

Authors:  Wandaliz Torres-García; Maribella Domenech
Journal:  Mol Biosyst       Date:  2017-11-21

7.  Ten unanswered questions in cancer: "If this is true, what does it imply"?

Authors:  Sarah R Amend; Amber E de Groot; Gonzalo Torga; Haley D Axelrod; Diane K Reyes; Kenneth C Valkenburg; Stephanie A Glavaris; Kenneth J Pienta
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

8.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.

Authors:  Liyan Zhuang; Jayoung Kim; Rosalyn M Adam; Keith R Solomon; Michael R Freeman
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

9.  Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell.

Authors:  Matthew J German; Azzedine Hammiche; Narasimhan Ragavan; Mark J Tobin; Leanne J Cooper; Shyam S Matanhelia; Andrew C Hindley; Caroline M Nicholson; Nigel J Fullwood; Hubert M Pollock; Francis L Martin
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

10.  Evolution of energy metabolism, stem cells and cancer stem cells: how the warburg and barker hypotheses might be linked.

Authors:  James E Trosko; Kyung-Sun Kang
Journal:  Int J Stem Cells       Date:  2012-05       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.